Roivant Sciences Ltd. (ROIV) Q2 2022 Earnings Call Transcript

Nov. 14, 2022 1:54 PM ETRoivant Sciences Ltd. (ROIV)
SA Transcripts profile picture
SA Transcripts

Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2022 Earnings Conference Call November 14, 2022 8:00 AM ET

Company Participants

Jeffrey Kalmus - Head, Strategic Finance

Matt Gline - CEO

Conference Call Participants

David Risinger - SVB Securities

Brian Cheng - JPMorgan

Corinne Jenkins - Goldman Sachs

Alexander Xenakis - Truist

Brendan Smith - Cowen

Louise Chen - Cantor

Neena Bitritto-Garg - Citigroup

Douglas Tsao - H.C. Wainwright

Yuchen Ding - Jefferies


Good day, and thank you for standing by. Welcome to the Roivant 2Q 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Jeffrey Kalmus, Head of Strategic Finance. Please go ahead.

Jeffrey Kalmus

Good morning, and thank you for joining today's call to discuss Roivant's financial results for the quarter ended September 30, 2022. Presenting today, we have Matt Gline, our Chief Executive Officer.

For those dialing in via conference call you can find the slides being presented today as well as the press release announcing these updates on our IR website at We'll also be providing the current slide numbers as we present to help you follow along.

I would like to remind you that we'll be making certain forward-looking statements during today's presentation that reflect our current views and expectations, including those related to our financial performance and the potential attributes of our products and product candidates.

We strongly encourage you to review the information that we filed with the SEC, including the earnings release and Form 10-Q filed this morning for more information regarding these forward-looking statements and related risks and uncertainties.

We'll begin with Matt Gline, who

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.